(ENOB) – StreetInsider.com Reports
-
Renovaro Biosciences (RENB) Responds to 'Hindenburg’s opinion piece'
-
Enochian Biosciences (ENOB) Announces that its Cancer Platform on Track for Trials in Humans Following FDA Review
-
Ferguson plc (FERG), Alphabet (GOOG), Tesla (TSLA), Coupang (CPNG) at top buy stock for Russell rebalancing - Jefferies
-
Enochian Biosciences' (ENOB) CEO Letter to Shareholders
-
Enochian Biosciences (ENOB) Achieves Full Compliance with NASDAQ Filing Requirements
-
Enochian Biosciences (ENOB) Receives Nasdaq Notice Regarding Delayed Filing of Form 10-Q
-
Implied Volatility Movement
-
Enochian Biosciences (ENOB) Issues CEO Letter to Shareholders
-
Enochian Biosciences (ENOB) Reports Findings from Internal Review of Scientific Data
-
Enochian Biosciences (ENOB) Mentioned Cautiously Again at Hindenburg Research
-
Enochian Biosciences (ENOB) Board Responds to Arrest of Co-Founder, Expresses Strong Confidence in the Promising Future of the Company
-
Enochian Biosciences (ENOB) Halted on Volatility for 5th Time, Down 48%
-
Founder and inventor of Enochian Biosciences (ENOB) key scientific breakthroughs, Serhat Gumrukcu, was just arrested in a murder for hire plot in California - Hindenburg
-
Enochian Biosciences (ENOB) Partners with Caring Cross to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
-
Enochian Biosciences (ENOB) Announces Up to $100M Common Stock Offering
-
Enochian Biosciences (ENOB) Announces Up to $100M Common Stock Offering
-
Enochian Biosciences (ENOB) Announces Successful Completion of FDA Pre-IND for Potential Cure for HIV: The Second Pre-IND in 1 month
-
Enochian Biosciences (ENOB) Board Member Resigns Over Conflict with Responsibilities with Important Public Sector Entity
-
Enochian Biosciences (ENOB) Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection
-
Enochian Biosciences (ENOB) Appoints Mark Dybul as CEO
-
Pre-Open Stock Movers 07/12: (STFC) (CLDX) (SPI) Higher; (TBLT) (DIDI) (RKT) Lower (more...)
-
Enochian Biosciences (ENOB) Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
-
Pre-Open Stock Movers 06/21: (LDL) (RAVN) (AEI) Higher; (MSTR) (RIOT) (COIN) Lower (more...)
-
Enochian Biosciences (ENOB) Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
-
Enochian Biosciences (ENOB) Halted on LUDP
-
Enochian Biosciences (ENOB) Announces $29 Million Registered Direct Offering of Common Stock
-
Enochian Biosciences (ENOB) Climbs 100% Pre-Open
-
Enochian Biosciences (ENOB) Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
-
Pre-Open Stock Movers 03/25: (ENOB) (CIDM) (RH) Higher; (RAD) (RIOT) (QS) Lower (more...)
-
Pre-Open Stock Movers 06/08: (DGLY) (MIK) (BA) Higher; (YTRA) (PENN) Lower (more...)
-
Enochian Biosciences (ENOB) Climbs 220% After Announcing Successful Completion of FDA INTERACT Meeting for Potential Cure for HIV
-
Enochian Biosciences (ENOB) Reports Successful Completion of FDA INTERACT Meeting for Potential Cure for HIV
-
Enochian Biosciences (ENOB) Announces FDA INTERACT Meeting for Potential Cure for HIV
-
Enochian Biosciences (ENOB) Acquires Exclusive License for Novel Hepatitis B Virus Potential Treatment or Cure
-
Enochian Biosciences (ENOB) Mentioned Negative at White Diamond Research
-
Pre-Open Movers 11/25: (SRNE) (MDCO) (TIF) Higher (CBAY) (UBER) (PRU) Lower (more...)
-
Enochian Biosciences (ENOB) Expands Infectious Disease Pipeline by Entering Pact to Acquire Exclusive License for Novel Hepatitis B Virus Treatment
Back to ENOB Stock Lookup
